193 related articles for article (PubMed ID: 23839065)
21. Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.
Ali H; Ahamed J; Hernandez-Munain C; Baron JL; Krangel MS; Patel DD
J Immunol; 2000 Dec; 165(12):7215-23. PubMed ID: 11120854
[TBL] [Abstract][Full Text] [Related]
22. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
De Yang ; Chen Q; Schmidt AP; Anderson GM; Wang JM; Wooters J; Oppenheim JJ; Chertov O
J Exp Med; 2000 Oct; 192(7):1069-74. PubMed ID: 11015447
[TBL] [Abstract][Full Text] [Related]
23. Human-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory response.
Bąbolewska E; Brzezińska-Błaszczyk E
Cell Immunol; 2015 Feb; 293(2):67-73. PubMed ID: 25577339
[TBL] [Abstract][Full Text] [Related]
24. A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor.
Elagoz A; Henderson D; Babu PS; Salter S; Grahames C; Bowers L; Roy MO; Laplante P; Grazzini E; Ahmad S; Lembo PM
Br J Pharmacol; 2004 Jan; 141(1):37-46. PubMed ID: 14662730
[TBL] [Abstract][Full Text] [Related]
25. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.
Kurosaka K; Chen Q; Yarovinsky F; Oppenheim JJ; Yang D
J Immunol; 2005 May; 174(10):6257-65. PubMed ID: 15879124
[TBL] [Abstract][Full Text] [Related]
26. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
[TBL] [Abstract][Full Text] [Related]
27. Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways.
Yanagisawa T; Ishii M; Takahashi M; Fujishima K; Nishimura M
Mol Biol Rep; 2020 Sep; 47(9):6841-6854. PubMed ID: 32886325
[TBL] [Abstract][Full Text] [Related]
28. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
[TBL] [Abstract][Full Text] [Related]
29. Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors.
Mishra NC; Rir-sima-ah J; Boyd RT; Singh SP; Gundavarapu S; Langley RJ; Razani-Boroujerdi S; Sopori ML
J Immunol; 2010 Jul; 185(1):588-96. PubMed ID: 20505147
[TBL] [Abstract][Full Text] [Related]
30. Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1.
Kim Y; Lee BD; Kim O; Bae YS; Lee T; Suh PG; Ryu SH
J Immunol; 2006 Mar; 176(5):2969-75. PubMed ID: 16493055
[TBL] [Abstract][Full Text] [Related]
31. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ
FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335
[TBL] [Abstract][Full Text] [Related]
32. RGS13 controls g protein-coupled receptor-evoked responses of human mast cells.
Bansal G; DiVietro JA; Kuehn HS; Rao S; Nocka KH; Gilfillan AM; Druey KM
J Immunol; 2008 Dec; 181(11):7882-90. PubMed ID: 19017978
[TBL] [Abstract][Full Text] [Related]
33. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
Rabiet MJ; Huet E; Boulay F
Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565
[TBL] [Abstract][Full Text] [Related]
34. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
[TBL] [Abstract][Full Text] [Related]
35. VIP modulates human macrophages phenotype via FPRL1 via activation of RhoA-GTPase and PLC pathways.
Harhous Z; Faour WH; El Zein N
Inflamm Res; 2021 Mar; 70(3):309-321. PubMed ID: 33502586
[TBL] [Abstract][Full Text] [Related]
36. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
37. A novel nonpeptide ligand for formyl peptide receptor-like 1.
Nanamori M; Cheng X; Mei J; Sang H; Xuan Y; Zhou C; Wang MW; Ye RD
Mol Pharmacol; 2004 Nov; 66(5):1213-22. PubMed ID: 15308762
[TBL] [Abstract][Full Text] [Related]
38. Activation of human monocytes by a formyl peptide receptor 2-derived pepducin.
Lee HY; Kim SD; Shim JW; Kim HJ; Kwon JY; Kim JM; Baek SH; Park JS; Bae YS
FEBS Lett; 2010 Sep; 584(18):4102-8. PubMed ID: 20804753
[TBL] [Abstract][Full Text] [Related]
39. Formyl-peptide receptor like 1: a potent mediator of the Ca2+ release-activated Ca2+ current ICRAC.
Li YS; Wu P; Zhou XY; Chen JG; Cai L; Wang F; Xu LM; Zhang XL; Chen Y; Liu SJ; Huang YP; Ye DY
Arch Biochem Biophys; 2008 Oct; 478(1):110-8. PubMed ID: 18652801
[TBL] [Abstract][Full Text] [Related]
40. Functional interaction between CTGF and FPRL1 regulates VEGF-A-induced angiogenesis.
Lee MS; Ghim J; Kim SJ; Yun YS; Yoo SA; Suh PG; Kim WU; Ryu SH
Cell Signal; 2015 Jul; 27(7):1439-48. PubMed ID: 25862954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
